Four new dinorsesterterpenoids, designated as trinulactones A-D (1-4), were isolated from the Streptomyces sp. S006 strain. All the compounds contained a tricyclic skeleton, which was attached to a highly oxygenated unsaturated γ-lactone. Their structures were determined by analysis of their spectroscopic data, mainly 1D, 2D NMR and HR-ESIMS data. In particular, compounds 3a/3b and 4a/4b were identified individually as atropisomers.
The most structurally diverse family of natural products is that of the terpenoids, more than 55 000 of which have been identified to date in all life forms [1] . However, terpenoid natural products with antibiotic properties isolated from bacteria are extremely rare [1, 2] . Novobiocin was isolated from Streptomyces niveus [3] as the first antibiotic with a terpenoid side chain, and was followed by the sesquiterpenoid antibiotic pentalenolactone from a Streptomyces sp., containing a pure terpenoid structure [4] . Up to date, only a few basic structures including dinorsesterterpenoids have been added to this limited compounds, most are prenylated scaffolds of different biosynthetic origins rather than pure terpenoids [1, 5] .
The characteristic of dinorsesterterpenoids is a tricyclic anti/anti/syn-configured perhydrophenanthrene backbone consisted of four isoprene units, of which the fourth comprises the β carbon of a γ-butyrolactone moiety. This structural feature can be observed in various sesterterpenoids from marine sponges, like the phospholipase A 2 inhibitors petrosaspongiolides from Petrosaspongia nigra [6] . However, only a few were of actinomycetes origin, e.g. phenalinolactones A-D isolated from Streptomyces sp. Tü 6071 [7] that exhibited antibacterial activity against a selection of Grampositive pathogens [8, 9] . This paper describes the fermentation, isolation and structure elucidation of four new dinorsesterterpenoids, namely trinulactones A-D (1-4), from the Streptomyces sp. S006 strain (Figure 1 ). Their structures were elucidated on the basis of 1D, 2D NMR and HR-ESIMS analysis. The antibacterial activities of compounds 1-4 were evaluated. (Tables 1 and 2 ) and 2D NMR spectrum ( 1 H-1 H COSY, HSQC, HMBC) (Figure 2 ), the structure of 1 was determined. In particular, three structure fragments (C-1/C-2/C-3, C-5/C-6/C-7 and C-9/C-11/C-12) were established on the basis of 1 H-1 H COSY correlations between H-2 and H-1/H-3, H-6 and H-5/H-7, and H-11 and H-9/H-12 (Figure 2, bold lines) , respectively. The methyl groups were found to show strong HMBC correlations to the respective carbon signals, including H 3 -19 to C-3, C-4, C-5 and C-20; H 3 -20 to C-3, C-4, C-5 and C-19; H 3 -21 to C-7, C-8, C-9 and C-15, H 3 -22 to C-12, C-13 and C-14; and H 3 -23 to C-1, C-5, C-9 and C-10 ( Figure  2 , green lines), which connected the three fragments (bold lines in Figure 2 ) to form a tricyclic scaffold.
An α-hydroxy-γ-methoxy-α,β-unsaturated-γ-lactone moiety was revealed by the NMR data at δ C 129.2 (C-15), δ H 5.98 (H-16), δ C 106.2 (C-16), δ C 169.8 (C-17) and δ C 143.6 (C-18) and further confirmed by the HMBC correlations from H-16 to C-17, C-18 and C-15 ( Figure 2 ). The highly oxygenated γ-butenolide moiety was determined to link to the tricyclic scaffold at C-14 on the basis of the HMBC correlations from H-14 to C-15 and C-18 ( Figure 2 ).
The relative configurations of 1 were determined on the basis of the NOESY correlations (Figure 2 ). The Z-configuration of the C-12/13 double bond was determined by the NOE correlation between H-12 and H 3 -22. The NOE correlations of H-3 to Me-19/H-5/H-1α (δ H 1.02), H-5 to H-9/H-7α (δ H 1.26), H-9 to H-11α (δ H 2.39) and H-11α to Me-21 suggested the α-face of these protons in the molecule (Figure 2, black dashed Tables 1 and 2 ). The NOESY cross-peaks observed from H-5 to C NMR spectra, some signals were displayed in pairs with partial overlap, revealing that 3 could be a pair of tautomers in a ratio ca. 2:1. The NMR data revealed that the major tautomer 3a was similar to 1, and had a tricyclic system linked with a γ-butenolide ring. The differences were found for the chemical shifts at C-12 (δ C 123.1d, δ H 5.60 in 1; δ C 83.6 d, δ H 3.39 in 3a), and C-13 ( C 133.7s in 1;  C 34.5d,  H 3.05 in 3a) indicated that the carbon-carbon double bond of  12,13 was replaced by a methine and oxymethine. In addition, the 1 H NMR spectra revealed the presence of a 2',3',6'-trisubstituted benzene ring on the basis of the proton signals at δ H 6.67 (H-4', J = 9.1 Hz); δ H 7.47 (H-5', J = 2.6, 9.0 Hz) and δ H 8.17 (H-7', J = 2.8 Hz), along with the HMBC correlations from H-4' to C-2' and C-6', H-7' to C-1', C-3' and C-5', and from MeNH-3' (δ H 2.75) to C-3' (Figure 2) . The linkage between C-19 and C-1' was supported by the HMBC correlations from H 2 -19 (δ H 4.38, 4.85) to C-1' (δ C 167.9) (Figure 2 ). The NOE correlations of H-12 to Me-22/Me-23, H-14 to Me-22/Me-23, and H-13 to Me-21, suggested the β-face of H-12 and α-face of H-13 in compound 3a (Figure 2 ).
The minor tautomer 3b was suggested presumably to be an atropisomer of 3a on the basis of the 1 H and 13 C NMR difference between that of 3a and 3b (Tables 1 and 2 In summary, four new dinorsesterterpenoids, namely trinulactones A-D (1-4), were isolated and characterized from Streptomyces sp. S006. Trinulactones represented a unique tricyclic terpene skeleton with a 6-6-6-fused ring system and an oxidized unsaturated γ-lactone. Prior to the current study, only phenalinolactones belonging to this type were identified [9, 11] . This study contributed tremendously to this group of dinorsesterterpenoids.
Experimental
General: Optical rotations were carried out using an Anton Paar MCP200 automatic polarrimeter. The UV spectra were obtained on a TU-1810 spectrophotometer (Beijing Purkinje General Instrument Co., LTD). IR spectra were recorded using a Thermo Nicolet 670 FT-IR spectrometer in KBr discs. NMR spectra were recorded on Bruker DRX-400 NMR spectrometer (Bruker Daltonics Inc., Billerica, MA, USA) with tetramethylsilane (TMS) as an internal standard. HR-ESIMS was carried out on a LTQ Velos Pro HRMS instrument (Thermo Scientific). Semi-preparative high-performance liquid chromatography (HPLC) was performed on an Agilent 1200 equipped with a ZORBAX XDB-C18 column ( 
Extraction and isolation:
To extract the metabolites, the fermented cultures were diced and extracted three times with EtOAc/MeOH/ AcOH (80:15:5, v/v/v) at room temperature. After the removal of solvents under vacuum, the crude extract was partitioned between H 2 O and EtOAc. The EtOAc-soluble partition was dissolved in 300 mL of 95% methanol and extracted three times with an equal volume of petroleum ether (PE) to afford the defatted MeOH extract (7.7 g). The MeOH extract was fractionated using MPLC (145 g RP-18 silica gel; eluted with 10%, 30%, 50%, 70% and 100% CH 3 CN, 1 L each) to yield five fractions (Fr. A-E). Fr. D (from 50% CH 3 CN, 1.0 g) was chromatographed over Sephadex LH-20 (140 g, MeOH) to afford 7 subfractions: Fr. D1-7. Further separation of Fr. D2 (528 mg) by MPLC (30 g RP-18 silica gel; 30%, 100 mL; 40%, 150 mL; 50%, 300 mL; 60%, 200 mL; 70%, 200 mL; 80%, 200 mL of MeOH-H 2 O and 200 mL MeOH, respectively) to yield Fr. D2a-2g. Fr. D2d (230 mg) was further fractionated using Sephadex LH-20 (60 g; acetone) and then purified by reversed-phase HPLC (43% CH 3 CN, 4 mL/min) to obtain 2 (t R 9.0 min, 4.7 mg). Fr. D2e was further purified by semipreparative HPLC (55% CH 3 CN, 4 mL/min) to yield 1 (t R 9.5 min, 6.4 mg). Fr. E (from 70% and 100% CH 3 CN, 823 mg) was chromatographed over Sephadex LH-20 eluted with MeOH to obtain Fr. E1-9. Combining with TLC results, Fr. E7 was subjected to CC over MPLC (30 g RP-18 silica gel; eluted with 50%, 60%, 70%, 80% MeOH) to give Fr. E7a-7e. Fr. E7c (38 mg) was subjected to silica gel CC (1. Supplementary data: 1D and 2D NMR, HR-ESIMS, IR spectra of compounds 1-4, and the NMR spectroscopic data of compounds 1-4 and phenalinolactone A can be found in the online version.
